The global Marine Omega-3 market size is predicted to grow from US$ 2709 million in 2025 to US$ 3605 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
Marine Omega-3, also called 蠅-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of Marine Omega-3 involved in human physiology are 伪-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can鈥檛 make them. Also they play a role in brain health as well as normal growth and development.
Global Marine Omega-3 key players include DSM, BASF, GC Rieber Oils, KD Pharma Group, Pelagia (EPAX), etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 55%, followed by South America, with a share about 20 percent. In terms of product, Marine Animals Source Omega-3 is the largest segment, with a share about 90%. And in terms of application, the largest application is Dietary Supplements, followed by Pet Foods, Fortified Food and Beverage, Infant Formula, Pharmaceuticals, etc.
The 鈥淢arine Omega-3 Industry Forecast鈥� looks at past sales and reviews total world Marine Omega-3 sales in 2024, providing a comprehensive analysis by region and market sector of projected Marine Omega-3 sales for 2025 through 2031. With Marine Omega-3 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marine Omega-3 industry.
This Insight Report provides a comprehensive analysis of the global Marine Omega-3 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marine Omega-3 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Marine Omega-3 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marine Omega-3 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marine Omega-3.
This report presents a comprehensive overview, market shares, and growth opportunities of Marine Omega-3 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Marine Animals Source Omega-3
Marine Plant Source Omega-3
Segmentation by Application:
Dietary Supplements
Fortified Food and Beverage
Infant Formula
Pharmaceuticals
Pet Foods
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma (Marine Ingredients)
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Orkla Health
LYSI
OLVEA Fish Oils
Hofseth BioCare
Nippon Suisan Kaisha
Bioprocess Algae
Shandong Yuwang Pharmaceutical
Maruha Nichiro Foods
Solutex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Marine Omega-3 market?
What factors are driving Marine Omega-3 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marine Omega-3 market opportunities vary by end market size?
How does Marine Omega-3 break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Marine Omega-3 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Marine Omega-3 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Marine Omega-3 by Country/Region, 2020, 2024 & 2031
2.2 Marine Omega-3 Segment by Type
2.2.1 Marine Animals Source Omega-3
2.2.2 Marine Plant Source Omega-3
2.3 Marine Omega-3 Sales by Type
2.3.1 Global Marine Omega-3 Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Marine Omega-3 Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Marine Omega-3 Sale Price by Type (2020-2025)
2.4 Marine Omega-3 Segment by Application
2.4.1 Dietary Supplements
2.4.2 Fortified Food and Beverage
2.4.3 Infant Formula
2.4.4 Pharmaceuticals
2.4.5 Pet Foods
2.4.6 Others
2.5 Marine Omega-3 Sales by Application
2.5.1 Global Marine Omega-3 Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Marine Omega-3 Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Marine Omega-3 Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Marine Omega-3 Breakdown Data by Company
3.1.1 Global Marine Omega-3 Annual Sales by Company (2020-2025)
3.1.2 Global Marine Omega-3 Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Marine Omega-3 Annual Revenue by Company (2020-2025)
3.2.1 Global Marine Omega-3 Revenue by Company (2020-2025)
3.2.2 Global Marine Omega-3 Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Marine Omega-3 Sale Price by Company
3.4 Key Manufacturers Marine Omega-3 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Marine Omega-3 Product Location Distribution
3.4.2 Players Marine Omega-3 Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Marine Omega-3 by Geographic Region
4.1 World Historic Marine Omega-3 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Marine Omega-3 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Marine Omega-3 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Marine Omega-3 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Marine Omega-3 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Marine Omega-3 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Marine Omega-3 Sales Growth
4.4 APAC Marine Omega-3 Sales Growth
4.5 Europe Marine Omega-3 Sales Growth
4.6 Middle East & Africa Marine Omega-3 Sales Growth
5 Americas
5.1 Americas Marine Omega-3 Sales by Country
5.1.1 Americas Marine Omega-3 Sales by Country (2020-2025)
5.1.2 Americas Marine Omega-3 Revenue by Country (2020-2025)
5.2 Americas Marine Omega-3 Sales by Type (2020-2025)
5.3 Americas Marine Omega-3 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Marine Omega-3 Sales by Region
6.1.1 APAC Marine Omega-3 Sales by Region (2020-2025)
6.1.2 APAC Marine Omega-3 Revenue by Region (2020-2025)
6.2 APAC Marine Omega-3 Sales by Type (2020-2025)
6.3 APAC Marine Omega-3 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Marine Omega-3 by Country
7.1.1 Europe Marine Omega-3 Sales by Country (2020-2025)
7.1.2 Europe Marine Omega-3 Revenue by Country (2020-2025)
7.2 Europe Marine Omega-3 Sales by Type (2020-2025)
7.3 Europe Marine Omega-3 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Marine Omega-3 by Country
8.1.1 Middle East & Africa Marine Omega-3 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Marine Omega-3 Revenue by Country (2020-2025)
8.2 Middle East & Africa Marine Omega-3 Sales by Type (2020-2025)
8.3 Middle East & Africa Marine Omega-3 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Marine Omega-3
10.3 Manufacturing Process Analysis of Marine Omega-3
10.4 Industry Chain Structure of Marine Omega-3
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Marine Omega-3 Distributors
11.3 Marine Omega-3 Customer
12 World Forecast Review for Marine Omega-3 by Geographic Region
12.1 Global Marine Omega-3 麻豆原创 Size Forecast by Region
12.1.1 Global Marine Omega-3 Forecast by Region (2026-2031)
12.1.2 Global Marine Omega-3 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Marine Omega-3 Forecast by Type (2026-2031)
12.7 Global Marine Omega-3 Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 DSM
13.1.1 DSM Company Information
13.1.2 DSM Marine Omega-3 Product Portfolios and Specifications
13.1.3 DSM Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 DSM Main Business Overview
13.1.5 DSM Latest Developments
13.2 BASF
13.2.1 BASF Company Information
13.2.2 BASF Marine Omega-3 Product Portfolios and Specifications
13.2.3 BASF Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BASF Main Business Overview
13.2.5 BASF Latest Developments
13.3 EPAX
13.3.1 EPAX Company Information
13.3.2 EPAX Marine Omega-3 Product Portfolios and Specifications
13.3.3 EPAX Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 EPAX Main Business Overview
13.3.5 EPAX Latest Developments
13.4 Golden Omega
13.4.1 Golden Omega Company Information
13.4.2 Golden Omega Marine Omega-3 Product Portfolios and Specifications
13.4.3 Golden Omega Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Golden Omega Main Business Overview
13.4.5 Golden Omega Latest Developments
13.5 TASA
13.5.1 TASA Company Information
13.5.2 TASA Marine Omega-3 Product Portfolios and Specifications
13.5.3 TASA Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 TASA Main Business Overview
13.5.5 TASA Latest Developments
13.6 Omega Protein
13.6.1 Omega Protein Company Information
13.6.2 Omega Protein Marine Omega-3 Product Portfolios and Specifications
13.6.3 Omega Protein Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Omega Protein Main Business Overview
13.6.5 Omega Protein Latest Developments
13.7 Croda
13.7.1 Croda Company Information
13.7.2 Croda Marine Omega-3 Product Portfolios and Specifications
13.7.3 Croda Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Croda Main Business Overview
13.7.5 Croda Latest Developments
13.8 KD Pharma (Marine Ingredients)
13.8.1 KD Pharma (Marine Ingredients) Company Information
13.8.2 KD Pharma (Marine Ingredients) Marine Omega-3 Product Portfolios and Specifications
13.8.3 KD Pharma (Marine Ingredients) Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 KD Pharma (Marine Ingredients) Main Business Overview
13.8.5 KD Pharma (Marine Ingredients) Latest Developments
13.9 GC Rieber
13.9.1 GC Rieber Company Information
13.9.2 GC Rieber Marine Omega-3 Product Portfolios and Specifications
13.9.3 GC Rieber Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GC Rieber Main Business Overview
13.9.5 GC Rieber Latest Developments
13.10 Polaris
13.10.1 Polaris Company Information
13.10.2 Polaris Marine Omega-3 Product Portfolios and Specifications
13.10.3 Polaris Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Polaris Main Business Overview
13.10.5 Polaris Latest Developments
13.11 Auqi
13.11.1 Auqi Company Information
13.11.2 Auqi Marine Omega-3 Product Portfolios and Specifications
13.11.3 Auqi Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Auqi Main Business Overview
13.11.5 Auqi Latest Developments
13.12 Kinomega
13.12.1 Kinomega Company Information
13.12.2 Kinomega Marine Omega-3 Product Portfolios and Specifications
13.12.3 Kinomega Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kinomega Main Business Overview
13.12.5 Kinomega Latest Developments
13.13 Skuny
13.13.1 Skuny Company Information
13.13.2 Skuny Marine Omega-3 Product Portfolios and Specifications
13.13.3 Skuny Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Skuny Main Business Overview
13.13.5 Skuny Latest Developments
13.14 Xinzhou
13.14.1 Xinzhou Company Information
13.14.2 Xinzhou Marine Omega-3 Product Portfolios and Specifications
13.14.3 Xinzhou Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Xinzhou Main Business Overview
13.14.5 Xinzhou Latest Developments
13.15 Anti-Cancer
13.15.1 Anti-Cancer Company Information
13.15.2 Anti-Cancer Marine Omega-3 Product Portfolios and Specifications
13.15.3 Anti-Cancer Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Anti-Cancer Main Business Overview
13.15.5 Anti-Cancer Latest Developments
13.16 Sinomega
13.16.1 Sinomega Company Information
13.16.2 Sinomega Marine Omega-3 Product Portfolios and Specifications
13.16.3 Sinomega Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Sinomega Main Business Overview
13.16.5 Sinomega Latest Developments
13.17 Orkla Health
13.17.1 Orkla Health Company Information
13.17.2 Orkla Health Marine Omega-3 Product Portfolios and Specifications
13.17.3 Orkla Health Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Orkla Health Main Business Overview
13.17.5 Orkla Health Latest Developments
13.18 LYSI
13.18.1 LYSI Company Information
13.18.2 LYSI Marine Omega-3 Product Portfolios and Specifications
13.18.3 LYSI Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 LYSI Main Business Overview
13.18.5 LYSI Latest Developments
13.19 OLVEA Fish Oils
13.19.1 OLVEA Fish Oils Company Information
13.19.2 OLVEA Fish Oils Marine Omega-3 Product Portfolios and Specifications
13.19.3 OLVEA Fish Oils Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 OLVEA Fish Oils Main Business Overview
13.19.5 OLVEA Fish Oils Latest Developments
13.20 Hofseth BioCare
13.20.1 Hofseth BioCare Company Information
13.20.2 Hofseth BioCare Marine Omega-3 Product Portfolios and Specifications
13.20.3 Hofseth BioCare Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Hofseth BioCare Main Business Overview
13.20.5 Hofseth BioCare Latest Developments
13.21 Nippon Suisan Kaisha
13.21.1 Nippon Suisan Kaisha Company Information
13.21.2 Nippon Suisan Kaisha Marine Omega-3 Product Portfolios and Specifications
13.21.3 Nippon Suisan Kaisha Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Nippon Suisan Kaisha Main Business Overview
13.21.5 Nippon Suisan Kaisha Latest Developments
13.22 Bioprocess Algae
13.22.1 Bioprocess Algae Company Information
13.22.2 Bioprocess Algae Marine Omega-3 Product Portfolios and Specifications
13.22.3 Bioprocess Algae Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Bioprocess Algae Main Business Overview
13.22.5 Bioprocess Algae Latest Developments
13.23 Shandong Yuwang Pharmaceutical
13.23.1 Shandong Yuwang Pharmaceutical Company Information
13.23.2 Shandong Yuwang Pharmaceutical Marine Omega-3 Product Portfolios and Specifications
13.23.3 Shandong Yuwang Pharmaceutical Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 Shandong Yuwang Pharmaceutical Main Business Overview
13.23.5 Shandong Yuwang Pharmaceutical Latest Developments
13.24 Maruha Nichiro Foods
13.24.1 Maruha Nichiro Foods Company Information
13.24.2 Maruha Nichiro Foods Marine Omega-3 Product Portfolios and Specifications
13.24.3 Maruha Nichiro Foods Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Maruha Nichiro Foods Main Business Overview
13.24.5 Maruha Nichiro Foods Latest Developments
13.25 Solutex
13.25.1 Solutex Company Information
13.25.2 Solutex Marine Omega-3 Product Portfolios and Specifications
13.25.3 Solutex Marine Omega-3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Solutex Main Business Overview
13.25.5 Solutex Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
